Top Industry Leaders in the Pseudotumor Cerebri Market
Avkare company specializing in IIH diagnostic tools is conducting a clinical trial comparing the accuracy of their MRI-based intracranial pressure (ICP) measurement device to the gold standard lumbar puncture. Positive results could significantly improve IIH diagnosis and treatment pathways.
Biogen is evaluating their anti-CGRP (calcitonin gene-related peptide) drug, rimegepant, in a Phase 3 clinical trial for patients with chronic IIH and refractory headaches. This could offer a non-surgical treatment option for IIH patients.
Actelion Pharmaceuticals (acquired by Janssen Pharmaceuticals) company focuses on drugs for rare diseases, including PTC. They are collaborating with patient advocacy groups and research institutions to advance IIH research and treatment options.
List of Pseudotumor Cerebri Key Companies in the Market
- Avkare,
- Beckersmith Medical Inc
- Corporation
- Johnson & Johnson Services
- MercuryPharma
- Phoenix Biomedical Corp
- Novast Holdings Ltd
- West-ward Pharmaceutical
- Magstim
- Integra Lifesciences
- Braun Melsungen
- Teva Pharmaceutical industries Ltd
- Lannett Company
- Elekta AB
- Heritage Pharmaceuticals Inc